WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients

By Chen Juan   Yin Jiye   Li Xiangping   Wang Ying   Zheng Yi   Qian Chenyue   Xiao Ling   Zou Ting   Wang Zhan   Liu Junyan   Zhang Wei   Zhou Honghao   Liu Zhaoqian  

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-11 ,pp. : 21011-21027

MDPI

Access to resources Recommend Favorite

Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity

By Hu Lei   Chen Shu-Hui   Lv Qiao-Li   Sun Bao   Qu Qiang   Qin Chong-Zhen   Fan Lan   Guo Ying   Cheng Lin   Zhou Hong-Hao  

International Journal of Environmental Research and Public Health, Vol. 13, Iss. 6, 2016-05 ,pp. : 545-545

MDPI

Access to resources Recommend Favorite

Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy

By  

Chemotherapy, Vol. 62, Iss. 4, 2017-04 ,pp. : 205-213

Karger

Access to resources Recommend Favorite

Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer

By  

Chemotherapy, Vol. 57, Iss. 6, 2012-01 ,pp. : 468-487

Karger

Access to resources Recommend Favorite

The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy

By Ormanns Steffen   Haas Michael   Remold Anna   Kruger Stephan   Holdenrieder Stefan   Kirchner Thomas   Heinemann Volker   Boeck Stefan  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. : 1094-1094

MDPI

Access to resources Recommend Favorite